The Phase III Clinical Report Was Finally Out

Sheng Changya stroked her fair, tender cheeks, unable to put her hands down. She stared at herself in the mirror for a long time before reluctantly leaving.

She no longer had any doubts about Sanqing Pharmaceutical's Whitening Drug.

Her heart was filled with the joy of having found a treasure.

As soon as she arrived at the office, she eagerly sent Wei Kang her feedback.

"As expected of a Sanqing product, President Wei. Your Whitening Cream is ridiculously effective."

"I applied it to the spots on my face, and they were all gone after just one night."

"I guarantee it as a professional: if this is made into a whitening skincare product and launched, it'll definitely sell like crazy."

"I'm sure the company will be very interested. President Wei, what do you have in mind regarding the form of cooperation?"

"Do you want to sell the formula, President Wei, or work with us?"

Wei Kang looked at the messages from the other end and could not help chuckling.

Anything produced by the system was naturally beyond question in terms of effectiveness.

Still, this woman was interesting. Rather than proposing a plan, she was asking what I wanted. Was she trying to sound me out?

He smiled faintly and replied, "That depends on your sincerity."

"I believe that once the trial data is released, you won't be the only ones interested in this drug."

"When that time comes, the highest bidder gets it. Manager Sheng, don't disappoint me."

Sheng Changya's smile froze as she read the reply. She silently sent back a message: "Understood, President Wei. We'll show the utmost sincerity."

She tossed her phone onto her desk and could not help smiling bitterly.

This President Wei did not seem easy to deal with, and showing the utmost sincerity would not be easy at all.

As a long-established top global Fortune 500 cosmetics group, Oulaiya was unquestionably an industry leader and a massive giant. Working there looked glamorous, especially with the added allure of the industry itself, which always attracted countless young women dreaming of beauty.

But after six years of struggling her way up from the bottom, from the lowest-ranking intern to assistant and then junior product manager in the mass cosmetics division, she had long understood the way these multinational corporations operated.

For foreign companies, unless domestic companies were powerful and industry competition was fierce, they would not respect the opinions of their Asia-Pacific divisions.

Otherwise, the domestic headquarters of every foreign company was nothing more than a group of puppets on strings. Decision-making power and R&D centers were overseas, while domestic departments had pitifully little autonomy.

To put it absurdly, headquarters wished the people in domestic divisions were robots that could be remotely controlled to execute operational instructions with precision.

In many foreign companies without domestic manufacturing plants, local staff were often responsible only for sales and after-sales service. Even the general manager was merely a steward with an impressive title, usually capable only of relaying headquarters' instructions, with no autonomy in any detail.

As for China's cosmetics industry, domestic brands were simply too weak, so the market had basically been divided up by foreign brands.

This left domestic divisions in an even weaker position. Any new proposal or good plan had to be reported layer by layer until it received approval from the foreign bosses before resources could be allocated for the next step.

The core business of the fast-moving consumer goods industry was brand marketing. As a product manager, Sheng Changya was responsible for every stage of a product under her brand, from research, design, and planning to competitor analysis, positioning, pricing, order budgeting, channel sales and training, as well as pre-launch and post-launch promotion, advertising, and sales campaigns.

But all her work was merely execution carried out under headquarters' allocation of resources. Her position was not high enough for her to propose any terms or make any decisions.

The only thing she could do was gather sufficiently detailed information and submit a report to the brand manager, hoping it would attract the company's attention.

Although she had great confidence in Wei Kang's Whitening Drug, she had no confidence that she could secure a sufficiently good offer.

Sheng Changya opened her performance evaluation metrics, looked them over, and sighed.

As a product manager promoted from intern, her career advancement had not been as fast as that of management trainees. She had worked diligently for six years, staying overtime until 10:30 every night, before finally receiving a promotion last year.

Who knew how many more years it would take for her to become a senior product manager, then advance further to brand manager?

By then, she would already be middle-aged and riddled with illnesses. And that was the most optimistic estimate. If she were less fortunate, it was entirely possible that she would remain in her current position until retirement.

She could not help shivering. No, she absolutely could not end up like that.

She had to do everything in her power to make this deal happen. Whether it meant buying the formula or jointly developing the product, as long as they could launch a powerful whitening product and successfully capture the market, it would become the most dazzling achievement of her career.

Just as Sheng Changya silently made up her mind for the sake of her career,

Wei Kang was joyfully flipping through the clinical trial report for the Whitening Drug.

As expected, Zhang Bo was fast.

This speedster truly lived up to his reputation as a long-time preferred partner.

If he said he would deliver it by the end of the month, he would never drag it into the next one.

The topical results were as stunning as ever.

There were no toxic reactions, no skin irritation, and no adverse side effects such as itching, erythema, or peeling.

Although the duration of the trial meant they could not determine the side effects of long-term use, such as rebound symptoms after stopping the medication or photosensitivity reactions.

Most importantly, its tolerability was excellent. None of the test subjects had experienced any allergic reactions.

This was the most important point for cosmetics, because one of the most troublesome issues in cosmetic sales was customers developing skin allergies after applying a product, resulting in a series of symptoms such as redness, swelling, dryness, tightness, itching, bumps, rashes, and stinging pain. In severe cases, it could even cause major damage to one's appearance, commonly known as a ruined face.

That was why major skincare brands all had to undergo long-term, large-scale sample testing to ensure their products were gentle enough that the vast majority of customers would not suffer allergic reactions. This was even more important than effectiveness.

Otherwise, customers used skincare products to become more beautiful, only to end up disfigured by allergies. That would completely destroy a brand's hard-earned reputation.

Only a system-produced formula could achieve such pure ingredients with no toxic side effects whatsoever.

Zhang Bo had also sent over the first batch of Phase III trial data for the anti-cancer drug.

This batch involved around one hundred people, and the results after one month of medication were astonishing.

Other than a few especially severe late-stage patients who were still under observation,

most cancer patients had been cured within a month.

The Cancer Cells in their bodies had all disappeared.

There were no signs of relapse for the time being, but what happened later was difficult to say.

After all, many primary cancers were largely caused by patients' unhealthy habits.

For example, lung cancer caused by smoking, oral cancer caused by chewing betel nut, liver cancer caused by drinking, staying up late, and irregular eating habits, and so on.

If patients continued maintaining such unhealthy lifestyles, it was hard to say whether cancer would recur.

No matter what, this data was already perfect.

Wei Kang contacted the hospital as well. Their trial group was larger, with around two to three hundred participants.

That was enough. These professional data were already sufficient to prove the anti-cancer drug's effectiveness.

As for what came next, Phase III trials would continue until the drug was launched.

After launch, Phase IV clinical trials would continue as well.

Phase IV was the stage of applied research conducted after a new drug entered the market.

It involved more participants and mainly studied the drug's further efficacy and adverse reactions, assessed the risks of use in special populations, and improved dosage regimens.

It was a long-term process that could not be accomplished overnight.

Wei Kang sent the electronic version of the Whitening Drug trial report to Sheng Changya.

He then went to find Sun Chengren to prepare for the upcoming press conference.

After discussing it, the two decided to schedule the new drug launch conference for the beginning of next month.

Before long, the news spread.

Everyone was looking forward to that day.

Especially to that legendary clinical trial report.

Every one of them was eager to see it for themselves.